Matches in Wikidata for { <http://www.wikidata.org/entity/Q91940345> ?p ?o ?g. }
Showing items 1 to 52 of
52
with 100 items per page.
- Q91940345 description "artículu científicu espublizáu en marzu de 2020" @default.
- Q91940345 description "im März 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91940345 description "scientific article published on 01 March 2020" @default.
- Q91940345 description "wetenschappelijk artikel" @default.
- Q91940345 description "наукова стаття, опублікована 1 березня 2020" @default.
- Q91940345 name "The Safety, Tolerability, and Pharmacokinetics Profile of BT-11, an Oral, Gut-Restricted Lanthionine Synthetase C-Like 2 Agonist Investigational New Drug for Inflammatory Bowel Disease: A Randomized, Double-Blind, Placebo-Controlled Phase I Clinical" @default.
- Q91940345 name "The Safety, Tolerability, and Pharmacokinetics Profile of BT-11, an Oral, Gut-Restricted Lanthionine Synthetase C-Like 2 Agonist Investigational New Drug for Inflammatory Bowel Disease: A Randomized, Double-Blind, Placebo-Controlled Phase I Clinical" @default.
- Q91940345 type Item @default.
- Q91940345 label "The Safety, Tolerability, and Pharmacokinetics Profile of BT-11, an Oral, Gut-Restricted Lanthionine Synthetase C-Like 2 Agonist Investigational New Drug for Inflammatory Bowel Disease: A Randomized, Double-Blind, Placebo-Controlled Phase I Clinical" @default.
- Q91940345 label "The Safety, Tolerability, and Pharmacokinetics Profile of BT-11, an Oral, Gut-Restricted Lanthionine Synthetase C-Like 2 Agonist Investigational New Drug for Inflammatory Bowel Disease: A Randomized, Double-Blind, Placebo-Controlled Phase I Clinical" @default.
- Q91940345 prefLabel "The Safety, Tolerability, and Pharmacokinetics Profile of BT-11, an Oral, Gut-Restricted Lanthionine Synthetase C-Like 2 Agonist Investigational New Drug for Inflammatory Bowel Disease: A Randomized, Double-Blind, Placebo-Controlled Phase I Clinical" @default.
- Q91940345 prefLabel "The Safety, Tolerability, and Pharmacokinetics Profile of BT-11, an Oral, Gut-Restricted Lanthionine Synthetase C-Like 2 Agonist Investigational New Drug for Inflammatory Bowel Disease: A Randomized, Double-Blind, Placebo-Controlled Phase I Clinical" @default.
- Q91940345 P1433 Q91940345-D04DBF0E-E23F-415F-B16E-3782521B341D @default.
- Q91940345 P1476 Q91940345-8E5CDE21-FC59-4E0B-A8C6-B4700B8939B6 @default.
- Q91940345 P2093 Q91940345-4255E77B-3F3E-4AAC-806B-7671843FACB4 @default.
- Q91940345 P2093 Q91940345-42654B47-0571-4C15-843A-39032C128749 @default.
- Q91940345 P2093 Q91940345-4290B3DB-F4D7-4985-8207-D7D3B88F758B @default.
- Q91940345 P2093 Q91940345-4872AAB4-9EC7-4DC5-BC75-314D61763FF3 @default.
- Q91940345 P2093 Q91940345-A049B5A4-2D7B-4B21-A7B5-AF56FB94BFF7 @default.
- Q91940345 P2093 Q91940345-C6F961C4-6929-4531-A2B8-0174C7386C92 @default.
- Q91940345 P2093 Q91940345-CC09FC2A-B1B3-4F0A-9324-9A83AA4F9E6F @default.
- Q91940345 P2093 Q91940345-D2591DAC-1813-4C96-A57A-D9B8F6ABBBAD @default.
- Q91940345 P304 Q91940345-27AFB0F7-546F-4A73-9A7D-4D4175966D27 @default.
- Q91940345 P31 Q91940345-15D27458-4C56-4292-B47D-5292F740EC17 @default.
- Q91940345 P356 Q91940345-696FE831-8F45-4FD8-A964-4D0C54C36072 @default.
- Q91940345 P433 Q91940345-B1671F7B-337F-49A0-A3DE-E74A8395659F @default.
- Q91940345 P478 Q91940345-88F24184-2DF3-4086-A71C-DE87C3DF3182 @default.
- Q91940345 P577 Q91940345-1E99A672-3CAB-407F-9C10-8AD136EAA717 @default.
- Q91940345 P698 Q91940345-284CBC10-C77A-4FFE-B56A-DEBA8456A3ED @default.
- Q91940345 P921 Q91940345-6A87DA01-78F4-456E-8FB3-18DEF05990DE @default.
- Q91940345 P921 Q91940345-ED61BDD8-83ED-47F4-A4F7-20EDCF0BB6C1 @default.
- Q91940345 P356 IZZ094 @default.
- Q91940345 P698 31077582 @default.
- Q91940345 P1433 Q15749161 @default.
- Q91940345 P1476 "The Safety, Tolerability, and Pharmacokinetics Profile of BT-11, an Oral, Gut-Restricted Lanthionine Synthetase C-Like 2 Agonist Investigational New Drug for Inflammatory Bowel Disease: A Randomized, Double-Blind, Placebo-Controlled Phase I Clinical Trial" @default.
- Q91940345 P2093 "Andrew Leber" @default.
- Q91940345 P2093 "Jean-Frederic Colombel" @default.
- Q91940345 P2093 "Josep Bassaganya-Riera" @default.
- Q91940345 P2093 "Jyoti Chauhan" @default.
- Q91940345 P2093 "Marion Ehrich" @default.
- Q91940345 P2093 "Nicholas Farinola" @default.
- Q91940345 P2093 "Raquel Hontecillas" @default.
- Q91940345 P2093 "Victoria Zoccoli-Rodriguez" @default.
- Q91940345 P304 "643-652" @default.
- Q91940345 P31 Q13442814 @default.
- Q91940345 P356 "10.1093/IBD/IZZ094" @default.
- Q91940345 P433 "4" @default.
- Q91940345 P478 "26" @default.
- Q91940345 P577 "2020-03-01T00:00:00Z" @default.
- Q91940345 P698 "31077582" @default.
- Q91940345 P921 Q323936 @default.
- Q91940345 P921 Q917447 @default.